<DOC>
	<DOCNO>NCT00000349</DOCNO>
	<brief_summary>The purpose study evaluate clinical safety issue pertain flupenthixol , cocaine , interaction , determine pretreatment flupenthixol modifies subjective well physiological effect cocaine . Taken together , relatively D-1 selective agent help determine extent DA-1 binding affect reinforce effect stimulant .</brief_summary>
	<brief_title>Infusion Laboratory : Protocol 5 ( Flupenthixol ) - 14</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Flupenthixol</mesh_term>
	<mesh_term>Flupenthixol decanoate</mesh_term>
	<criteria>M/F , age 2150 . Meet DSMIV criterion cocaine dependence . Agree condition study sign inform consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nuring woman . Dependence ETOH benzodiazepine sedative/hypnotics . Acute hepatitis . Other medical condtions deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>